This article is more than 5 years old. Information may no longer be current.
Cancer researcher to lead Einstein’s Belfer Institute
Click Here to Manage Email Alerts
Cancer researcher Anne R. Bresnick, PhD, has been named director of Belfer Institute for Advanced Biomedical Studies at Albert Einstein College of Medicine.
“Anne’s impressive research, along with her nearly 19-year teaching career at Einstein, makes her exceptionally qualified to mentor our next generation of young scientists,” dean Allen M. Spiegel, MD, said in a press release. “Her well-known commitment to supporting and guiding students and early career scientists is a clear indicator that Anne will enrich the postdoctoral experience at Einstein and enhance the college of medicine’s position as a preeminent training ground in biomedical science."
Anne R. Bresnick
Bresnick, professor of biochemistry, succeeds Jonathan M. Backer, MD, who was named chair of the department of molecular pharmacology at the college of medicine.
The Belfer Institute for Advanced Biomedical Studies is dedicated to providing a focus for integrating postdoctoral training programs at Einstein and serving as an advocate for postdoctoral issues. The goal of the institute is to provide the best possible scientific and social training environment for postdoctoral researchers.
Dr. Bresnick’s research focuses on the S100A4 calcium-binding protein, which directly regulates tumor cell motility and tumor metastasis. Her studies are aimed at developing a treatment to improve the cancer survival rate of patients by preventing the disease from spreading to disparate locations in the body.